Accessibility Menu
Omeros Stock Quote

Omeros (NASDAQ: OMER)

$7.74
(-1.7%)
-0.13
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$7.74
Daily Change
(-1.7%) $0.13
Day's Range
$7.43 - $8.03
Previous Close
$7.74
Open
$7.77
Beta
1.42
Volume
9,808
Average Volume
3,350,317
Market Cap
526.8M
Market Cap / Employee
$7.74M
52wk Range
$2.95 - $13.6
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
-$2.11
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Omeros Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
OMER+82.55%-27.39%-6.2%-11%
S&P+14.5%+93.32%+14.09%+529%

Omeros Company Info

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$0.00M0.0%
Gross Profit-$0.20M3.8%
Market Cap$175.78M-25.3%
Market Cap / Employee$0.87M0.0%
Employees2022.0%
Net Income-$25.89M60.2%
EBITDA-$32.15M45.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$1.90M-10.2%
Accounts Receivable$28.22M-4.9%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$339.25M-19.1%
Short Term Debt$42.76M71.0%

Ratios

Q2 2025YOY Change
Return On Assets-49.24%-4.0%
Return On Invested Capital-72.22%1.8%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$21.95M52.3%
Operating Free Cash Flow-$21.94M52.3%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book-1.85-3.71-2.61-0.82-75.27%
Price to Tangible Book Value-1.85-3.71-2.61-0.82-75.27%
Price to Free Cash Flow TTM2.75-
Enterprise Value to EBITDA-15.36-25.62-24.22-16.4586.26%
Free Cash Flow Yield36.4%-
Return on Equity-576.3%-
Total Debt$433.44M$423.28M$415.05M$382.01M-14.03%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.